Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
DNA

Ginkgo Bioworks Holdings (DNA) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $13.00 +14.6% on the day -14.7% over 12 months 52-week range $5.48 – $15.83

Share price and insider trades

DNA closeInsider buyInsider sale
5101520NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $2,303 on 2026-08-24 · Steven P. CoenSold $2,557 on 2026-05-22 · Steven P. CoenSold $2,576 on 2026-04-17 · Steven P. CoenSold $4,772 on 2026-03-16 · Steven P. CoenSold $5,941 on 2026-07-17 · Steven P. CoenSold $6,543 on 2025-12-15 · Steven P. CoenSold $8,670 on 2026-01-20 · Steven P. CoenSold $17,909 on 2025-10-17 · Steven P. CoenSold $35,400 on 2026-09-15 · Christian O HenrySold $36,045 on 2026-10-05 · Steven P. CoenSold $212,626 on 2026-04-13 · Steven P. CoenSold $854,642 on 2026-04-08 · Barry Canton, Jason R Kelly, Reshma P. ShettySold $870,394 on 2026-04-09 · Barry Canton, Jason R Kelly, Reshma P. ShettySold $1,603,989 on 2026-04-10 · Barry Canton, Reshma P. Shetty
Bought, 12 months$0
Sold, 12 months$3.7M
Insiders buying0
Insiders selling5

Ginkgo Bioworks Holdings insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $3.7M of DNA stock on the open market.

DNA insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $109K sold (3 trades)Q4 2025Q1 2026: $13K sold (2 trades)Q1 2026Q2 2026: $3.5M sold (11 trades)Q2 2026Q3 2026: $44K sold (3 trades)Q3 2026Q4 2026: $36K sold (1 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$36K1
Q3 2026—0$44K3
Q2 2026—0$3.5M11
Q1 2026—0$13K2
Q4 2025—0$109K3

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day4.6×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Ginkgo Bioworks Holdings, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $3.7M. 2 of 20 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Oct 7SEC Steven P. CoenSee Remarks Sell Plan 2,40349,448 held (−5%) $15.00 $36K -13.3% —
Sep 16SEC Christian O HenryDirector Sell 5,00019,310 held (−21%) $7.08 $35K +83.6% —
Aug 25SEC Steven P. CoenSee Remarks Sell 33051,851 held (−1%) $6.98 $2K +86.2% —
Jul 20SEC Steven P. CoenSee Remarks Sell 75251,438 held (−1%) $7.90 $6K +64.6% —
May 26SEC Steven P. CoenSee Remarks Sell 30750,704 held (−1%) $8.33 $3K +56.1% —
Apr 20SEC Steven P. CoenSee Remarks Sell 32450,268 held (−1%) $7.95 $3K +63.5% —
Apr 14SEC Steven P. CoenSee Remarks Sell 33,17149,849 held (−40%) $6.41 $213K +102.8% —
Apr 13SEC Barry Canton10% Owner Sell 124,727436,422 held (−22%) $6.43 $802K +102.2% —
Apr 13SEC Reshma P. ShettySee Remarks Sell 124,727436,422 held (−22%) $6.43 $802K +102.2% —
Apr 10SEC Jason R KellySee Remarks Sell 109,767316,483 held (−26%) $6.40 $703K +103.1% —
Apr 10SEC Jason R KellySee Remarks Sell 97,015426,250 held (−19%) $6.93 $672K +87.6% —
Apr 10SEC Barry Canton10% Owner Sell 13,155351,684 held (−4%) $6.93 $91K +87.6% —
Apr 10SEC Reshma P. ShettySee Remarks Sell 13,155351,684 held (−4%) $6.93 $91K +87.6% —
Apr 10SEC Barry Canton10% Owner Sell 13,116338,568 held (−4%) $6.40 $84K +103.1% —
Apr 10SEC Reshma P. ShettySee Remarks Sell 13,116338,568 held (−4%) $6.40 $84K +103.1% —
Mar 18SEC Steven P. CoenSee Remarks Sell 7089,099 held (−7%) $6.74 $5K +92.9% —
Jan 22SEC Steven P. CoenSee Remarks Sell 9728,321 held (−10%) $8.92 $9K +45.7% —
Dec 16SEC Steven P. CoenSee Remarks Sell 7367,488 held (−9%) $8.89 $7K +46.2% —
Oct 21SEC Steven P. CoenSee Remarks Sell 1,3126,738 held (−16%) $13.65 $18K -4.8% —
Oct 3SEC Steven P. CoenSee Remarks Sell Plan 5,6095,503 held (−50%) $15.00 $84K -13.3% —

Insiders at Ginkgo Bioworks Holdings, Inc.

InsiderBoughtSoldLast filingScore
Jason R KellySee Remarks — $1.4M Apr 10, 2026 —
Barry Canton10% Owner — $977K Apr 13, 2026 —
Reshma P. ShettySee Remarks — $977K Apr 13, 2026 —
Steven P. CoenSee Remarks — $384K Oct 7, 2026 —
Christian O HenryDirector — $35K Sep 16, 2026 —

DNA stock: common questions

Are Ginkgo Bioworks Holdings, Inc. insiders buying DNA stock?

In the past 12 months, 0 insiders reported open-market purchases of DNA worth $0.

Are Ginkgo Bioworks Holdings, Inc. insiders selling DNA stock?

5 insiders reported sales worth $3.7M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is DNA's 52-week range?

Over the past year DNA has traded between $5.48 and $15.83. It last closed at $13.00 on Oct 9, 2026.